Clinical trial
Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)
NCT03128021 is registered in ClinicalTrials.gov with Howard Aizenstein as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)
- Lead sponsor
- Howard Aizenstein
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 24, 2017
- Completion date
- August 30, 2023
- Enrollment
- 57 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.